Apyx Medical(APYX)

Focus: Apyx Medical is a public medical device company focused on plastic surgery and cosmetic applications, with approximately 750 employees and $48M in FY2025 revenue.

Unknown

Profile data last refreshed 10h ago · AI intelligence enriched 2mo ago

Funding Stage

PUBLIC

Employees

501-1000

Open Jobs

About Apyx Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Apyx Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

4/9 — Basic

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Revenue

$48M

FY2025

Key Products

Renuvion

Skin Laxity

Growth

Primary marketed platform with 8 associated trials demonstrating active development in skin rejuvenation applications.

J-Plasma

Facial Wrinkles

Help build intelligence for Apyx Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Established public company with 13-year track record and proven revenue base ($48M FY2025)
Focused niche in high-margin cosmetic/aesthetic medicine with growing consumer demand
11% R&D intensity supports innovation in emerging technologies like plasma-based treatments

Watch Out For

Declining revenue trajectory ($52M FY2024 to $48M FY2025) signals market headwinds
Consecutive years of significant losses ($18.7M FY2024, $23.5M FY2025) despite positive revenue, with shrinking cash runway ($44M to $32M)
Only 6 active job openings and minimal hiring activity (5 unknowns, 1 corporate) suggests limited growth

Generated by Claude from Apyx Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Complementary plasma-based technology for facial aesthetics with 2 trials supporting clinical validation.

Pipeline & Clinical Trials

Renuvion

Skin Laxity

N/A

Clinical Trials (5)

NCT05605691Post-Market Lower Eyelid Treatment With Renuvion in Greece

N/A

NCT04146467Renuvion APR Device to Improve the Appearance of Lax Tissue in the Neck and Submental Region

N/A

NCT05323630Evaluation of the Use of the Renuvion APR System in the Labia

N/A

+2 more

J-Plasma

Facial Wrinkles

N/A

Clinical Trials (2)

NCT03286283The Use of J-Plasma® for Dermal Resurfacing

N/A

NCT02658851Cold Plasma for the Reduction of Lymphoceles Following PLND

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2011

Portfolio: 10 clinical trials

Publications: 25 in PubMed

SEC Filings: 2 available

Financials (FY2025)

Revenue

$48M8%

R&D Spend

$5M(11%)7%

Net Income

-$23M

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

Biomedical application of cold plasma: navigating through plasma types and devices by antimicrobial effectiveness and tissue tolerance.

Advanced therapeutics

2025

PMID:40964152

Reply to Comment to: A Three-Dimensional Approach to Male Chest Enhancement: A Surgical Algorithm Based on 300 Cases.

Aesthetic plastic surgery

Showing 5 of 10 publications

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo